Nanoform small is powerful logo Nanoform small is powerful logo
Loading..
Loading..
  • Contact Us
  • About Nanoform
    About Nanoform
    • Vision, mission and values
    • Organization
      Board of Directors
      CEO and Management Team
    • Success stories
    • Corporate Responsibility
  • Technology
    Technology
    • CESS®
      STARMAP®
    • Biologics
      Formulations
    • Case studies
  • Services
    Services
    • GMP Manufacturing
  • Corporate Governance
    Corporate Governance
    • Corporate Governance Statements
      General meeting
      Annual General Meeting 2023
      General meetings
    • The Board of Directors
      Board of Directors
      Duties of the Board of Directors
      Authorisations
      Board committees
      Remuneration of the Board
    • CEO and Management Team
      Remuneration
      Audit
      Internal Control and Risk Management
      Code of conduct
    • Articles of Association
      Insider administration
      Disclosure policy
      Transcations of managers
  • Investors
    Investors Investerare Sijoittajat
    • Financial Reports and Presentations
      Press releases
      Subscribe
    • Share and shareholders
      Share information
      Share capital development
      Certified Adviser
      Analyst Coverage
      Ownership structure
      Notifications of major shareholdings
      Manager Transactions
    • IPO 2020
    • Investor calendar
      Contact
    • Finansiella rapporter och presentationer
      Pressmeddelanden
      Prenumerera
    • Aktien och aktieägare
      Aktieinformation
      Aktiekapitalets utveckling
      Certified Adviser
      Analytiker
      Ägarstruktur
      Anmälan om betydande aktieägare
      Transaktioner utförda av personer i ledande ställning
    • Börsnotering
    • Investerarkalender
      Kontakt
    • Taloudelliset raportit ja esitykset
      Tiedotteet
      Tilaaminen
    • Osake ja osakkeeomistajat
      Tiedot osakkeesta
      Osakepääoman kehitys
      Hyväksytty neuvonantaja
      Analyytikot
      Omistusrakenne
      Ilmoitukset merkittävistä osakkeenomistajista
      Johtohenkilöiden liiketoimet
    • Listautuminen
    • Sijoittajakalenteri
      Yhteystiedot
  • Media
    Media
    • Press releases
      News
      Case studies
    • Pharmaceutical events
      Articles & videos
    • Subscribe
      Brochure
    • Contact
  • Careers
  • Contact

Investor calendar

2020
  • Upcoming events
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • All years
Financial Calendar
    • Pharmaceutical events
    • All events
April 7, 2020

Annual General Meeting 2020

July 29 - August 27, 2020

Silent Period / Closed Window

August 28, 2020, at 08:10 EEST

Half-year Financial Report for January-June 2020

September 1, 2020

Extraordinary General Meeting 2020

November 17 - November 18, 2020

Jefferies Virtual Healthcare Conference, London

November 18, 2020

Nanoform to present at Avanza Börsdag on November 18th

November 25, 2020

Nordea Innovation Seminar, Stockholm

November 27, 2020

Interim Report for January-September 2020

December 9, 2020

Danske Bank Global Teleconference Call to Institutional Investors

December 12th, 2020 at 21.30 EEST/20.30 CEST

Nanoform is featured on Advancements TV with Ted Danson at business news channel CNBC

Contact us

+358 29 370 0150
[email protected]

  • Privacy notice
  • Cookies

Subscribe

Read more about our protection of your personal data.

Nanoform Finland Oyj
Cultivator II, Viikinkaari 4
FI-00790 Helsinki
Finland
Company number: 2730572-8